BIOMAT Database Logo BIOMAT Database Logo

Pubertal gynecomastia. 2002

V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Istituto di Pediatria, Università di Ferrara, Ferrara, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D011627 Puberty A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT. Puberties
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012739 Gonadal Steroid Hormones Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE. Gonadal Steroid Hormone,Sex Hormone,Sex Steroid Hormone,Sex Steroid Hormones,Sex Hormones,Hormone, Gonadal Steroid,Hormone, Sex,Hormone, Sex Steroid,Hormones, Gonadal Steroid,Hormones, Sex Steroid,Steroid Hormone, Gonadal,Steroid Hormone, Sex,Steroid Hormones, Gonadal,Steroid Hormones, Sex
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Pubertal gynecomastia.
May 2002, Journal of pediatric endocrinology & metabolism : JPEM,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
[Pubertal gynecomastia].
January 1972, Deutsche medizinische Wochenschrift (1946),
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
[Pubertal idiopathic gynecomastia].
January 1994, Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Management of pubertal gynecomastia.
November 1977, The Journal of pediatrics,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Tamoxifen treatment for pubertal gynecomastia.
January 2003, International journal of adolescent medicine and health,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Clomiphene in pubertal-adolescent gynecomastia.
January 1978, The Journal of pediatrics,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Pituitary-gonadal function in pubertal gynecomastia.
December 1971, The Journal of pediatrics,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Plasma phthalate levels in pubertal gynecomastia.
January 2010, Pediatrics,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
[Plasma prolactin levels and pubertal gynecomastia].
July 1983, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
V De Sanctis, and S Bernasconi, and G Bona, and M Bozzola, and F Buzi, and G Radetti, and F Rigon, and L Tatò, and G Tonini, and C De Sanctis
Gynecomastia in prepubertal and pubertal men.
August 2008, Current opinion in pediatrics,
Copied contents to your clipboard!